Group 1 - The company announced that its subsidiary, Sichuan Yongle Lude Biotechnology Development Co., Ltd. (referred to as "Yongle Lude"), plans to introduce investors through a capital increase and share expansion [2] - 聚力杭实 (Hangzhou Julihang Investment Partnership) intends to invest 37 million yuan in cash to subscribe for the newly increased registered capital of Yongle Lude, which will also result in the company waiving its preemptive rights [2] - Following the completion of this transaction, Yongle Lude's registered capital will increase from 60 million yuan to 97 million yuan, and the company's direct ownership in Yongle Lude will decrease from 66% to approximately 40.82% [2] Group 2 - Yongle Lude will still be classified as a controlled subsidiary within the company's consolidated financial statements despite the change in ownership percentage [2] - The legal representative of Yongle Lude has been changed from Hu Weiting to Ji Guangming due to operational management needs [2] - As of the date of this announcement, Yongle Lude has received the 37 million yuan capital increase from 聚力杭实 and has completed the necessary business registration changes, obtaining a new business license from the market supervision administration [2]
路德科技：关于控股子公司增资及变更法定代表人完成工商变更登记的公告